Cargando…
Direct oral anticoagulants: patient reported adherence and minor bleedings
Data regarding adherence and minor bleeding on direct oral anticoagulants in everyday life are still sparse. Inclusion criteria: treatment initiated with dabigatran, rivaroxaban or apixaban in non-valvular atrial fibrillation patients from a center in northern Sweden between 2011 and 2019 (n = 668)....
Autores principales: | Hayat, Amina, Själander, Anders, Wallvik, Jonas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284977/ https://www.ncbi.nlm.nih.gov/pubmed/37119356 http://dx.doi.org/10.1007/s11239-023-02797-8 |
Ejemplares similares
-
Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
por: Wallvik, Niklas, et al.
Publicado: (2020) -
Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study
por: Sjögren, Vilhelm, et al.
Publicado: (2017) -
Direct oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation and CKD G3–G5D
por: Welander, Frida, et al.
Publicado: (2023) -
Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation
por: Jansson, M., et al.
Publicado: (2023) -
Bleeding complications from the direct oral anticoagulants
por: Sholzberg, Michelle, et al.
Publicado: (2015)